OVERVIEW

Clinical Trials Nexus Europe 2020 is organized by Procurement Direct Ltd and will be held from Nov 26 - 27, 2020 at Crowne Plaza Paris - Charles de Gaulle, Paris, Ile-de-France, France.

Description:
Clinical Trials Nexus European Series facilitate meaningful interactions and the exchange of information between pharmaceutical, biotechnology and research organisations corporate leaders to accelerate the development of novel therapies to address unmet needs & on-going pandemic. The Pharma and Bio-Tech companies are consistently evolving and new clinical studies, technologies and advancements in care and treatments have augmented the efficiency and at the same time the complexity of clinical trials has increased, with tests being carried out in a highly structured and closely coordinated manner. Clinical Trials Nexus intends to focus on the global health and clinical trials around Europe, patient recruitment, site selection, real-world data, data integration & Strategy, outsourcing, vendor management, quality (QbD) in Trial Conduct, risk-based monitoring, and other significant topics that play a key role in clinical trials will be addressed along with innovative sessions on new technologies, effective and quality collaborations.

Key Topics of 2020:
• Early Clinical Development
• Cro Selection Process
• Covid-19: Present and Future Evaluation
• Patient Centric Trials
• Data and Technology
• Operations and Outsourcing

KEY DATES

Event Start Date
26 Nov, 2020
Event Start Date
Event End Date
27 Nov, 2020
Event End Date

SPECIALITIES

Research and Clinical Research

SUGGESTED HOTELS

CONFERENCE VENUE

LocationCrowne Plaza Paris - Charles de Gaulle
8 Allée du Verger, Roissy-en-France

RELATED CONFERENCES & LIVE WEBINARS

Jul 23 - 24, 2026 | Vienna, Wien, AT

Research and Clinical Research
More actions
AT€350

Oct 29 - 30, 2026 | Orlando, Florida, USA

Oncology
More actions
US$235
Featured Conference
By Global Regenerative Academy (GRA)

Nov 20 - 22, 2026 | Paphos, Paphos, CY

Research and Clinical Research
14 ECMECs
More actions
US$149